Human β-defensins kill Candida albicans in an energy-dependent and salt-sensitive manner without causing membrane disruption

Antimicrobial Agents and Chemotherapy

Volumn 51, Issue 1, 2007, Pages 154-161

  Vylkova, Slavena ^a   Nayyar, Namrata ^a   Li, Wansheng ^a   Edgerton, Mira ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA DEFENSIN; BETA DEFENSIN 2; BETA DEFENSIN 3; CALCEIN; CALCIUM; CELL MEMBRANE PROTEIN; HISTATIN 5; MAGNESIUM; PROTEIN SSA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CANDIDA ALBICANS; FUNGICIDAL ACTIVITY; MEMBRANE DAMAGE; MEMBRANE PERMEABILITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADENOSINE TRIPHOSPHATE; ANTIFUNGAL AGENTS; BETA-DEFENSINS; BLOTTING, WESTERN; CALCIUM CHLORIDE; CANDIDA ALBICANS; CELL MEMBRANE; CELL WALL; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; PHOSPHATES; SALIVARY PROTEINS; SODIUM CHLORIDE;

EID: 33845968880     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.00478-06     Document Type: Article

References (32)

1. Baev, D., A. Rivetta, S. Vylkova, J. N. Sun, G. F. Zeng, C. L. Slayman, and M. Edgerton. 2004. The TRK1 potassium transporter is the critical effector for killing of Candida albicans by the cationic protein, histatin 5. J. Biol. Chem. 279:55060-55072.
2. Bals, R., X. Wang, Z. Wu, T. Freeman, V. Bafna, M. Zasloff, and J. M. Wilson. 1998. Human beta-defensin 2 is a salt-sensitive peptide antibiotic expressed in human lung. J. Clin. Investig. 102:874-880.
3. Chen, X., F. Niyonsaba, H. Ushio, D. Okuda, I. Nagaoka, S. Ikeda, K. Okumura, and H. Ogawa. 2005. Synergistic effect of antibacterial agents human beta-defensins, cathelicidin LL-37 and lysozyme against Staphylococcus aureus and Escherichia coli. J. Dermatol. Sci. 40:124-132.
4. Dawes, C. 2004. Factors influencing salivary flow rate and composition, p. 32-49. In W. M. Edgar, C. Dawes, and D. M. O-Mullane (ed.), Saliva and oral health, 3rd ed. British Dental Association, London, United Kingdom.
5. Dong, J., S. Vylkova, X. S. Li, and M. Edgerton. 2003. Calcium blocks fungicidal activity of human salivary histatin 5 through disruption of binding with Candida albicans. J. Dent. Res. 82:748-752.
6. Edgerton, M., S. E. Koshlukova, T. E. Lo, B. G. Chrzan, R. M. Straubinger, and P. A. Raj. 1998. Candidacidal activity of salivary histatins. Identification of a histatin 5-binding protein on Candida albicans. J. Biol. Chem. 273: 20438-20447.
7. Edgerton, M., and S. E. Koshlukova. 2000. Salivary histatin 5 and its similarities to the other antimicrobial proteins in human saliva. Adv. Dent. Res. 14:16-21.
8. Epstein, J. B., and B. Polsky. 1998. Oropharyngeal candidiasis: a review of its clinical spectrum and current therapies. Clin. Ther. 20:40-57.
9. Feng, Z., B. Jiang, J. Chandra, M. Ghannoum, S. Nelson, and A. Weinberg. 2005. Human beta-defensins: differential activity against candidal species and regulation by Candida albicans. J. Dent. Res. 84:445-450.
10. Garcia, J. R., F. Jaumann, S. Schulz, A. Krause, J. Rodrigues-Jimenez, U. Forssmann, K. Adermann, E. Kluver, C. Vogelmeier, D. Becker, R. Hedrich, W. G. Forsmann, and R. Bals. 2001. Identification of a novel, multifunctional beta-defensin (human beta-defensin 3) with specific antimicrobial activity. Its interaction with plasma membranes of Xenopus oocytes and the induction of macrophage chemoattraction. Cell Tissue Res. 306:257-264.
11. Harder, J., J. Bartels, E. Christophers, and J. M. Schroder. 2001. Isolation and characterization of human beta-defensin-3, a novel human inducible peptide antibiotic. J. Biol. Chem. 276:5707-5713.
12. Hoover, D. M., K. R. Rajashankar, R. Blumenthal, A. Puri, J. J. Oppenheim, O. Chertov, and J. Lubkowski. 2000. The structure of human beta-defensin-2 shows evidence of higher order oligomerization. J. Biol. Chem. 275:32911-32918.
13. Hoover, D. M., Z. Wu, K. Tucker, W. Lu, and J. Lubkowski. 2003. Antimicrobial characterization of human beta-defensin 3 derivatives. Antimicrob. Agents Chemother. 47:2804-2809.
14. Joly, S., C. Maze, P. B. McCray, and J. M. Guthmiller. 2004. Human beta-defensins 2 and 3 demonstrate strain-selective activity against oral microorganisms. J. Clin. Microbiol. 42:1024-1029.
15. Koshlukova, S. E., T. L. Lloyd, M. W. Araujo, and M. Edgerton. 1999. Salivary histatin 5 induces non-lytic release of ATP from Candida albicans leading to cell death. J. Biol. Chem. 274:18872-18879.
16. Lihrer, R. I., T. Ganz, D. Szklarek, and M. E. Selsted. 1988. Modulation of the in vitro Candidacidal activity of human neutrophil defensins by target cell metabolism and divalent cations. J. Clin. Investig. 81:1829-1835.
17. Li, X. S., M. S. Reddy, D. Baev, and M. Edgerton. 2003. Candida albicans Ssa1/2p is the cell envelope binding protein for human salivary histatin 5. J. Biol. Chem. 278:28553-28561.
18. Lupetti, A., A. Paulusma-Annema, M. M. Welling, S. Senesi, J. T. van Dissel, and P. H. Nibbering. 2000. Candidacidal activities of human lactoferrin peptides derived from the N terminus. Antimicrob. Agents Chemother. 44:3257-3263.
19. Maisetta, G., G. Batoni, S. Esin, G. Raco, D. Bottai, F. Favilli, W. Florio, and M. Campa. 2005. Susceptibility of Streptococcus mutans and Actinobacillus actinomycetemcomitans to bactericidal activity of human β-defensin 3 in biological fluids. Antimicrob. Agents Chemother. 49:1245-1248.
20. Mathews, M., H. P. Jia, J. M. Guthmiller, G. Losh, S. Graham, G. K. Johnson, B. F. Tack, and P. B. McCray, Jr. 1999. Production of β-defensin antimicrobial peptides by the oral mucosa and salivary glands. Infect. Immun. 67:2740-2745.
21. Morrison, G. M., C. A. Semple, F. M. Kilanowski, R. E. Hill, and J. R. Dorin. 2003. Signal sequence conservation and mature peptide divergence within sub-groups of the murine beta-defensin gene family. Mol. Biol. Evol. 20:460-470.
22. Odds, F. C. 2003. Synergy, antagonism, and what the chequerboard puts between them. J. Antimicrob. Chemother. 52:1.
23. Ouhara, K., H. Komatsuzawa, S. Yamada, H. Shiba, T. Fujiwara, M. Ohara, K. Sayama, K. Hashimoto, H. Kurihara, and M. Sugai. 2005. Susceptibilities of periodontopathogenic and cariogenic bacteria to antibacterial peptides, β-defensins and LL37, produced by human epithelial cells. J. Antimicrob. Chemother. 55:888-896.
24. Pfaller, M. A., L. Boyken, R. J. Hollis, S. A. Messer, S. Tendolkar, and D. J. Diekema. 2005. In vitro susceptibilities of clinical isolates of Candida species, Cryptococcus neoformans, and Aspergillus species to itraconazole: global survey of 9,359 isolates tested by Clinical and Laboratory Standards Institute broth microdilution methods. J. Clin. Microbiol. 43:3807-3810.
25. Schibli, D. J., H. N. Hunter, V. Aseyev, T. D. Starner, J. M. Wiencek, P. B. McCray Juniorperiod, B. F. Tack, and H. J. Vogel. 2002. The solution structures of the human beta-defensins lead to a better understanding of the potent bactericidal activity of HBD3 against Staphylococcus aureus. J. Biol. Chem. 277:8279-8289.
26. Schneider, J. J., A. Unholzer, M. Schaller, M. Schafer-Korting, and H. C. Korting. 2005. Human defensins. J. Mol. Med. 83:587-595.
27. Singh, P. K., B. F. Tack, P. B. McCray Juniorperiod, and M. J. Welsh. 2000. Synergistic and additive killing by antimicrobial factors found in human airway surface liquid. Am. J. Physiol. Lung Cell Mol. Physiol. 279:799-805.
28. Tallarida, R. J. 2000. Calculation for combination drug analysis, p. 57-75. In R. J. Tallarida (ed.), Drug synergism and dose-effect data analysis, 1st ed. Chapman & Hall/CRC Press, Boca Radon, FL.
29. Tanida, T., T. Okamoto, A. Okamoto, H. Wang, T. Hamada, E. Ueta, and T. Osaki. 2003. Decreased excretion of antimicrobial proteins and peptides in saliva of patients with oral candidiasis. J. Oral Pathol. Med. 32:586-594.
30. Tao, R., R. J. Jurevic, K. K. Coluton, M. T. Tsutsui, M. C. Roberts, J. R. Kimball, N. Welsh, J. Berndt, and B. A. Dale. 2005. Salivary antimicrobial peptide expression and dental caries experience in children. Antimicrob. Agents Chemother. 49:3883-3888.
31. Vylkova, S., X. S. Li, J. C. Berner, and M. Edgerton. 2006. Distinct antifungal mechanisms: β-defensins require Candida albicans Ssa protein, while Trk1p mediates activity of cysteine-free cationic peptides. Antimicrob. Agents Chemother. 50:324-331.
32. Xu, Y., I. Ambudkar, H. Yamagishi, W. Swaim, T. J. Walsh, and B. C. O'Connell. 1999. Histatin 3-mediated killing of Candida albicans: effect of extracellular salt concentration on binding and internalization. Antimicrob. Agents Chemother. 43:2456-2462.